News about "drug discovery"

Illumina Completes USD 350 Million Acquisition of SomaLogic to Expand Multiomics and Proteomics Capabilities

Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.

Drug Discovery | 02/02/2026 | By News Bureau |  184

FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes

Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.

Drug Discovery | 22/01/2026 | By News Bureau |  104

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer

Adaptive Biotechnologies has signed two immune receptor licensing agreements with Pfizer, covering a T-Cell Receptor (TCR) discovery collaboration in rheumatoid arthritis and access to Adaptive’s proprietary TCR-antigen datasets for immunology R&D.

Drug Discovery | 16/12/2025 | By News Bureau |  116

IIT Madras and Ohio State Researchers Develop AI Framework That Mimics Chemical Synthesis for Drug Discovery

Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.

Drug Discovery | 06/11/2025 | By Darshana |  239

Syngene International Invests in Peptide Laboratory and Advanced Automation

Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.

Drug Discovery | 16/10/2025 | By Dineshwori |  170

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.

Drug Discovery | 05/04/2025 | By Aishwarya |  276

TME Pharma Partners with aimed analytics for AI-Driven Drug Discovery and Optimization

This partnership supports TME Pharma's strategic plan, announced on December 4, 2024, by enhancing its capability profile for potential strategic partners.

Drug Discovery | 30/01/2025 | By Aishwarya |  634

NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery

Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.

Drug Discovery | 15/01/2025 | By Aishwarya |  429

Acellera Rolls Out AceForce 1.0 to Advance Drug Discovery

AceForce 1.0 is a groundbreaking tool in computational chemistry and drug discovery, offering quantum-level accuracy by leveraging a proprietary training set of millions of quantum mechanical (QM) calculations.

Drug Discovery | 08/01/2025 | By Aishwarya |  444

Axcelead DDP Signs Drug Discovery Service Deal with Astellas for Targeted Protein Degraders

Under the agreement, Axcelead DDP will support Astellas’ targeted protein degrader discovery utilizing DegLeadTM Platform and contribute to the generation of breakthrough new drug candidate compounds.

Drug Discovery | 27/12/2024 | By Aishwarya |  297